Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids Source: Eur Respir J 2003; 21: 989-993 Year: 2003
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Acute effects of intermittent and continuous normocapnic hyperpnea on lung function and airway resistance in asthmatics Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Systemic effects of fluticasone on blood eosinophils in bronchiectasis Source: Eur Respir J, 56 (3) 2002005; 10.1183/13993003.02005-2020 Year: 2020
Dose response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Eur Respir J 2011; 37: 206-209 Year: 2011
Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Influence of a low dose of BDP-HFA on methacholine or exercise-induced lung hyperinflation in mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005
Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats Source: Eur Respir J 2002; 20: 873-879 Year: 2002
Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations Source: Eur Respir J 2016; 48: 104-114 Year: 2016
Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002
Effect of bronchial neutrophilia on airway remodeling in asthma Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019